A study to determine effective and tolerable titration scheme for OROS-Methylphenidate in Children with Attention-deficit hyperactivity disorder

Update Il y a 4 ans
Reference: EUCTR2015-001070-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of the study is to investigate the clinical benefit of switching children with ADHD from immediate-release methylphenidate (IR-MPH) to OROS-methylphenidate under the correct dosage conversion scheme.


Inclusion criteria

  • Attention Deficit Hyperactivity Disorder

Links